Results of using targeted methods in repeat prostate biopsy in patients with negative results of primary systemic biopsy
Open Access
- 18 December 2025
- journal article
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 21 (3) , 82-90
Abstract
Background. Biopsy is the standard for prostate cancer (PCa) diagnostics. The false negative rate of 12-core biopsy is about 30 %. To improve the quality of detection of clinically significant PCa (csPCa) (ISUP (International Society of Urological Pathology) score 2 or more) during repeat biopsy, it is possible to use targeted diagnostic methods, such as HistoScanning (HS), cognitive fusion biopsy, hardware fusion biopsy. Aim. To compare targeted prostate biopsy methods: HS, cognitive fusion, hardware fusion biopsy for the diagnosis of csPCa during repeat biopsy in patients with negative primary biopsy result. Materials and methods. A prospective comparative study was conducted. The study included 320 men with suspected PCa after negative primary biopsy. Median age was 68 years, PSA level was 9.1 ng/mL, prostate volume was 57 cm2, PSA density was 0.15 ng/ml/cm2. Patients were divided into three groups depending on repeat biopsy method: group 1 – HS, group 2 – cognitive fusion biopsy, group 3 – hardware fusion biopsy; the groups were comparable with each other. Results. PCa was diagnosed after repeat biopsy using HS, cognitive fusion, hardware fusion biopsy in 25.4, 45.5, 44.2 % of cases, respectively; csPCa was diagnosed in 4.5, 22.2, 18.2 % of cases, respectively. In all groups, PCa and csPCa were most often diagnosed with lesions in both target and standard biopsies. The use of targeting in the HS group did not provide an advantage in diagnostics. In the hardware fusion biopsy group, in the absence of cancer in standard cores, csPCa was diagnosed more often in targeted biopsies, compared with the cognitive fusion technique (11.8 % versus 7.5 %). With both fusion biopsy techniques, more malignant forms of PCa were diagnosed in targeted biopsies, compared with standard cores, however, due to standard cores, 23.5 % of PCa cases were not missed, of which 3.75 % were csPCa. The use of transrectal cognitive fusion technique showed a comparable result with perineal hardware fusion biopsy for diagnosing transition zone cancer. Conclusion. The HS technique did not show advantages in diagnosing PCa during repeat biopsy. The use of cognitive fusion and hardware fusion techniques allows to improve diagnostics of both PCa and csPCa during repeat biopsy. According to our data, it is recommended to use targeted cores in addition to the standard ones. The use of cognitive fusion biopsy showed comparable results with hardware fusion in diagnostics of transition zone prostate cancer.Keywords
This publication has 11 references indexed in Scilit:
- Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive vs Software Fusion, A Multicenter AnalysisUrology, 2024
- Bi-parametric MRI/TRUS fusion targeted repeat biopsy after systematic 10-12 core TRUS-guided biopsy reveals more significant prostate cancer especially in anteriorly located tumorsActa Radiologica Open, 2022
- Recent Global Patterns in Prostate Cancer Incidence and Mortality RatesEuropean Urology, 2020
- The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative BiopsiesEuropean Urology, 2019
- Multi-parametric MRI/US fusion guided biopsy for the diagnosis of prostate cancer. Оur experienceUrologiia, 2018
- Prostate cancer detection in patients with prior negative biopsy undergoing cognitive-, robotic- or in-bore MRI target biopsyWorld Journal of Urology, 2018
- Computer-aided transrectal ultrasound: does prostate HistoScanning™ improve detection performance of prostate cancer in repeat biopsies?BMC Urology, 2015
- Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound‐fusion biopsy for the diagnosis of prostate cancerBJU International, 2014
- Prostate Cancer Diagnosis: Multiparametric MR-targeted Biopsy with Cognitive and Transrectal US–MR Fusion Guidance versus Systematic Biopsy—Prospective Multicenter StudyRadiology, 2013
- Extended and Saturation Prostatic Biopsy in the Diagnosis and Characterisation of Prostate Cancer: A Critical Analysis of the LiteratureEuropean Urology, 2007